BRPI0809661A2 - Composição farmacêutica estabilizada contendo pregabalina - Google Patents
Composição farmacêutica estabilizada contendo pregabalinaInfo
- Publication number
- BRPI0809661A2 BRPI0809661A2 BRPI0809661-9A2A BRPI0809661A BRPI0809661A2 BR PI0809661 A2 BRPI0809661 A2 BR PI0809661A2 BR PI0809661 A BRPI0809661 A BR PI0809661A BR PI0809661 A2 BRPI0809661 A2 BR PI0809661A2
- Authority
- BR
- Brazil
- Prior art keywords
- pregabaline
- pharmaceutical composition
- composition containing
- stabilized pharmaceutical
- stabilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007019071A DE102007019071A1 (de) | 2007-04-23 | 2007-04-23 | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
PCT/EP2008/003285 WO2008128775A2 (en) | 2007-04-23 | 2008-04-23 | Stabilised pharmaceutical composition containing pregabaline |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0809661A2 true BRPI0809661A2 (pt) | 2014-10-14 |
Family
ID=39777371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0809661-9A2A BRPI0809661A2 (pt) | 2007-04-23 | 2008-04-23 | Composição farmacêutica estabilizada contendo pregabalina |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100151012A1 (pt) |
EP (1) | EP2148656A2 (pt) |
JP (1) | JP2010524991A (pt) |
KR (1) | KR20100015764A (pt) |
CN (1) | CN101663025A (pt) |
AU (1) | AU2008240960A1 (pt) |
BR (1) | BRPI0809661A2 (pt) |
CA (1) | CA2681587A1 (pt) |
DE (1) | DE102007019071A1 (pt) |
EA (1) | EA200901365A1 (pt) |
IL (1) | IL201035A0 (pt) |
WO (1) | WO2008128775A2 (pt) |
ZA (1) | ZA200907450B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010115612A2 (en) * | 2009-04-10 | 2010-10-14 | Synthon B.V. | Pregabalin compositions |
TR200909613A1 (tr) | 2009-12-22 | 2011-07-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Pregabalinin farmasötik bileşimleri. |
EP2389934A1 (en) | 2010-05-25 | 2011-11-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-Release Tablet Formulations of Pregabalin |
TR201005241A1 (tr) * | 2010-05-25 | 2012-01-23 | Sanovel �La� San. Ve T�C. A.�. | Kontrollü salım sağlayan pregabalin solüsyon formülasyonu. |
EP2389933A1 (en) | 2010-05-25 | 2011-11-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | Controlled-Release Pregabalin Compositions |
CN102793685B (zh) * | 2012-08-14 | 2017-09-22 | 浙江华海药业股份有限公司 | 含有普瑞巴林的口服胶囊及其制备方法 |
WO2015031228A1 (en) | 2013-08-30 | 2015-03-05 | Merck Sharp & Dohme Corp. | Oral pharmaceutical formulation of omarigliptin |
CN103948564B (zh) * | 2014-04-22 | 2016-05-11 | 青岛市中心医院 | 一种普瑞巴林胶囊及其制备方法 |
ES2871026T3 (es) * | 2015-10-14 | 2021-10-28 | Lesvi Laboratorios Sl | Composiciones de pregabalina |
CN105520918B (zh) * | 2015-12-31 | 2018-12-11 | 常州市阳光药业有限公司 | 普瑞巴林胶囊 |
JP6919119B2 (ja) * | 2017-01-23 | 2021-08-18 | 日新製薬株式会社 | 3位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 |
JP2019142834A (ja) * | 2017-07-31 | 2019-08-29 | 大原薬品工業株式会社 | プレガバリン並びに好適な賦形剤を含有する固形製剤 |
PL3720424T3 (pl) * | 2017-12-08 | 2022-12-27 | F. Hoffmann-La Roche Ag | Preparat farmaceutyczny |
JP6504638B1 (ja) * | 2018-05-31 | 2019-04-24 | 武田テバファーマ株式会社 | 錠剤及びその製造方法 |
CN112245404A (zh) * | 2020-11-02 | 2021-01-22 | 成都晶富医药科技有限公司 | 一种普瑞巴林胶囊及其制备方法 |
CA3199166A1 (en) | 2020-12-04 | 2022-06-09 | Cecilia Jannette Munoz Martinez | Stable, coated, and solid pharmaceutical drug composition containing an opioid analgesic and an antiepileptic to relieve pain |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9019198A (en) * | 1997-08-19 | 1999-03-08 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants |
DK1077692T3 (da) | 1998-05-15 | 2004-12-06 | Warner Lambert Co | Aminosyrestabiliserede gabapentin- og pregabalinpræparater og fremgangsmåder til fremstilling deraf |
ID26395A (id) | 1998-05-15 | 2000-12-21 | Warner Lambert Comapny | Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya |
WO2001001983A1 (en) * | 1999-07-02 | 2001-01-11 | Warner-Lambert Company | A synergistic combination: gabapentin and pregabalin |
FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
AP2002002501A0 (en) * | 1999-10-07 | 2002-06-30 | Warner Lambert Co | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. |
US7022678B2 (en) | 2001-03-30 | 2006-04-04 | Warner-Lambert Company | Pregabalin lactose conjugates |
CA2446574C (en) * | 2001-05-25 | 2008-04-01 | Neema Mahesh Kulkarni | Liquid pharmaceutical composition |
US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
WO2004084879A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmaceuticals, Inc. | Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators |
EP1543831A1 (en) * | 2003-12-18 | 2005-06-22 | Pfizer GmbH Arzneimittelwerk Gödecke | Pregabalin composition |
WO2006121557A1 (en) | 2005-05-10 | 2006-11-16 | Teva Pharmaceutical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
-
2007
- 2007-04-23 DE DE102007019071A patent/DE102007019071A1/de not_active Withdrawn
-
2008
- 2008-04-23 BR BRPI0809661-9A2A patent/BRPI0809661A2/pt not_active Application Discontinuation
- 2008-04-23 CA CA002681587A patent/CA2681587A1/en not_active Abandoned
- 2008-04-23 US US12/450,858 patent/US20100151012A1/en not_active Abandoned
- 2008-04-23 WO PCT/EP2008/003285 patent/WO2008128775A2/en active Application Filing
- 2008-04-23 EA EA200901365A patent/EA200901365A1/ru unknown
- 2008-04-23 AU AU2008240960A patent/AU2008240960A1/en not_active Abandoned
- 2008-04-23 JP JP2010504536A patent/JP2010524991A/ja active Pending
- 2008-04-23 EP EP08749084A patent/EP2148656A2/en not_active Withdrawn
- 2008-04-23 CN CN200880012632A patent/CN101663025A/zh active Pending
- 2008-04-23 KR KR1020097021975A patent/KR20100015764A/ko not_active Application Discontinuation
-
2009
- 2009-09-17 IL IL201035A patent/IL201035A0/en unknown
- 2009-10-23 ZA ZA200907450A patent/ZA200907450B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL201035A0 (en) | 2010-05-17 |
EA200901365A1 (ru) | 2010-04-30 |
EP2148656A2 (en) | 2010-02-03 |
WO2008128775A3 (en) | 2009-04-23 |
JP2010524991A (ja) | 2010-07-22 |
AU2008240960A1 (en) | 2008-10-30 |
ZA200907450B (en) | 2010-06-30 |
WO2008128775A2 (en) | 2008-10-30 |
CA2681587A1 (en) | 2008-10-30 |
KR20100015764A (ko) | 2010-02-12 |
DE102007019071A1 (de) | 2008-10-30 |
CN101663025A (zh) | 2010-03-03 |
US20100151012A1 (en) | 2010-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
LTPA2018005I1 (lt) | Farmacinė kompozicija | |
BRPI0809661A2 (pt) | Composição farmacêutica estabilizada contendo pregabalina | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
BRPI0810928A2 (pt) | "composição farmacêutica" | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
NL2000690A1 (nl) | Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine. | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0812354A2 (pt) | Composição farmacêutica não-aquosa. | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
BRPI0719398A2 (pt) | Composição farmacêutica. | |
BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
BRPI0908859A2 (pt) | composição farmacêutica estabilizada de líquído único contedo docetaxel | |
DK2285413T3 (da) | Farmaceutisk sammensætning | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
BRPI0921313A2 (pt) | composição farmaucêutica | |
DK2966175T3 (da) | Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
BRPI0914182A2 (pt) | composto, e, composição farmacêutica | |
BRPI0912171A2 (pt) | composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |